Reported Jul 1, 2026 · Terminated · Updated Sep 16, 2026

Red Blood Cells, Leukocytes Reduced

New York Blood Center Inc.

Moderate riskThis product could cause temporary or reversible health problems — stop using it.

What you should do

Stop using the affected lot and contact the recalling firm for the return or refund process. Check the FDA enforcement report for lot-level detail.

Firm contact: New York Blood Center Inc · 737 Pelham Blvd · St. Paul, MN · 55114-1739

Is this the product you have?

  • Red Blood Cells, Leukocytes Reduced
Lot codes and dates
    • W051525513776
    • W051521506871
    • W051521507136
    • W051521509336
Amount recalled
4

This recall covers 2 products

The agency filed one notice per product. You are reading one of them; the other one is below.

Where it was sold

Why it was recalled

Red Blood Cells, Leukocytes Reduced, collected from a donor who previously tested reactive for the antibody to Hepatitis B core antigen (anti-HBc) on more than one occasion, were distributed.

This product could cause temporary or reversible health problems — stop using it.

Want the full recall guide?

The guide adds the identifying codes laid out for scanning, symptoms to watch for, a timeline, and news coverage of this recall.

Free recall alerts

Get alerted about new New York Blood Center Inc. recalls

One email when a matching recall is published. No account, no cost, unsubscribe in one click.

Where this came from

Source: U.S. Food & Drug Administration (Enforcement Report)

Read the FDA (weekly enforcement report) notice

Notice updated Jun 24, 2026 · Data as of Sep 19, 5:36 PM UTC

RecallNow is not a government agency. Every fact on this page is published by the FDA, USDA or CPSC and links back to their notice.